ThinkGenetic locates individuals with diagnosed and undiagnosed genetic diseases using artificial intelligence (AI) solutions. Co-founded by a patient advocate and a genetic counselor, we know firsthand that people can wait a long time to receive a genetic diagnosis. People also have the power within themselves to shorten this diagnostic odyssey. ThinkGenetic helps individuals harness this power by offering trustworthy information to guide them to the help they need, faster. Undiagnosed individuals, patients, and families are our focus and this sets us apart.
In addition to crafting and implementing our innovative genetics solutions, ThinkGenetic, Inc also funds a small number of grant projects that align with ThinkGenetic's mission. All grant recipients are non-profits in the United States with no more than 10% of grant funds to be used for Indirect costs. Interested applicants should email firstname.lastname@example.org for additional information.
ThinkGenetic Leadership Team
CEO and Founder
Dave comes from successful careers in internet technology (IT) and business. As regional vice president of sales at Electronic Data Systems (EDS), he helped grow the company from $100M to $2.5B before it was acquired by General Motors (GM). He went on the found two successful startups, where he still serves in a leadership capacity.
As a rare genetic disease patient, Dave founded ThinkGenetic to provide patients and healthcare providers access to the best materials related to rare genetic diseases and disorders.
As the CEO of ThinkGenetic, Dave brings his business acumen to the table, along with his personal experiences as a patient and father living with a rare genetic disease.
President and Founder
Len has 15 years of experience successfully running internet technology (IT) and digital marketing firms. During that time, he founded successful startups, including ThinkGenetic, which continue to grow and evolve. He served in the U.S. Navy and has worked in a wide-range of engineering and technology fields, including nuclear, aerospace, and IT. Len started out as an engineer before moving into management roles in Business Intelligence and Plant Management.
As the President of ThinkGenetic, Len has worked closely on the development of the data systems and underlying technologies that make our products function.
Dawn Jacob Laney
Dawn is a leader in the fields of genetics and education as well as a certified genetic counselor with over 17 years of experience. In 2016, she was formally recognized as a leader in the field of rare genetic diseases by the National Organization for Rare Disorders. Dawn's academic roles include Assistant Professor of Human Genetics, Director of the Genetic Clinical Trials Center, and Program Leader of the Lysosomal Storage Disease Center (LSDC) Program at Emory University School of Medicine.
As a Founder of ThinkGenetic, Dawn is instrumental in designing and developing the rich, informative content that ThinkGenetic uses as our knowledgebase.
Ruth brings over 10 years of experience to efficiently and creatively lead our marketing efforts, having worked as a social media and marketing professional within a digital marketing agency, internally at a premier IBM IT company, and as a private consultant. Using her formal background in Communications as a strong base, she has gained expertise in critical aspects of inbound digital marketing, digital media channels, and creative design.
As the Marketing Director, Ruth anticipates and manages ThinkGenetic's marketing needs in a dynamic environment. She maintains strong engagement with patients, partners, healthcare providers, and other communities to further the ThinkGenetic mission effectively and successfully.
Board of Directors
Ted is the Founder and Former President and Chief Executive Officer of Chiswick Trading, Inc., and a former Advisor to Guaranty First Bank. He is the Managing Member of Paris Trust LLC and currently serves on the Boards of UV Tech Systems, and Peddock Capital Advisors (a private wealth management firm). Also, Ted is a Governing Trustee at the Dana Farber Cancer Institute, as well as a member of their Science Committee. In addition, Ted is a current member of Boynton Angels, Inc.
Dr. Grabowski is a leading authority in genetic diseases and metabolic disorders. He is the former Director of Human Genetics (DHG) at the Cincinnati Children's Hospital Medical Center (CCHMC) as well as Professor in the Departments of Molecular Genetics and Biochemistry, and Pediatrics, at the University of Cincinnati College of Medicine. In 2014, after over twenty years at CCHMC, Dr. Grabowski joined Synageva BioPharma as their Chief Scientific Officer to continue the pursuit of therapies for rare, devastating, inherited diseases. Now, he holds positions of Professor Emeritus of Pediatrics and Genetics at CCHMC, and is a Consultant for and/or member of Scientific Advisory Boards for several biotech companies, including Alexion Pharmaceuticals, Lysosomal Therapeutics, Inc., and elpidera (a Moderna venture), and is Chief Scientific Officer of Kiniksa Pharmaceuticals.
Gary is a graduate of the United States Naval Academy where he was a classmate of ThinkGenetic co-founder Len Barker. After graduating with a degree in Electrical Engineering, Gary entered the Navy nuclear power program where he served on a fast attack submarine. He remained in the Navy reserves after his five years of active duty and retired from the reserves as a Navy Captain after 24 years of service. After his active duty time Gary attended law school at NYU and then worked for the law firm Baker Botts LLP in Manhattan as a patent attorney for more than 20 years before joining Google as a corporate patent attorney in 2012.
Board of Advisors
Michael J Gambello
Dr. Gambello is the Section Chief of the Division of Medical Genetics at Emory University. In this role, he coordinates the wide spectrum of genetic services at Emory, actively expanding the Division to provide timely and state of the art genetic care. His clinical responsibilities include the diagnosis and care for children and adults with birth defects, lysosomal storage diseases and inborn errors of metabolism. Dr. Gambello received his BA from the Massachusetts Institute of Technology and MD, Ph.D. from the University of Rochester School of Medicine and Dentistry.